


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.44%
+5.98%
-13.61%
-15.65%
CC
Chemours Company
$18.02
Strengths

Trading below its fair value
Risk Analysis

Earnings are forecast to decrease

Downgraded on weak valued
CC Price Performance
$15.11 (+19.26%)
$12.79 (+40.89%)
$15.91 (+13.26%)
$14.4 (+25.14%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Loss widens YoY
Earnings decline YoY
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to decrease
Trading below its fair value
CC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CC Street Sentiment is bullish but have mixed views on the near-term outlook
CC has Low risk level
Risk Indicators
Sentiments overview associated with events and the stock performance
Average key support and resistance price levels
Recent Upgrades and Downgrades
Dec 04, 2025
Reiterate
Neutral
JP Morgan
Nov 12, 2025
Reiterate
Buy
UBS
Nov 11, 2025
Reiterate
Buy
Truist Securities
Nov 11, 2025
Reiterate
Outperform
RBC
Sep 24, 2025
Price Target Raised
Buy
Truist
What is CC current stock price?
What are CC stock strengths?
What is CC Risk Level?
What is CC market cap and volume?
What is CC current Stock IQ?
Should I buy CC stock right now?
Is CC a Strong Buy right now?
What does a 'Strong Buy' rating mean for CC?
What does a 'Strong Sell' rating mean for CC?
What factors influence CC's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
CC
Chemours Company
Current Price
$18.02

CC Price Performance
$15.11 (+19.26%)
$12.79 (+40.89%)
$15.91 (+13.26%)
$14.4 (+25.14%)
CC Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Loss widens YoY
Earnings decline YoY
Rating
Rating
Downgraded on weak valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to decrease
Trading below its fair value
CC Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
CC Street Sentiment is bullish but have mixed views on the near-term outlook
CC has Low risk level
Risk Indicators
Average key support and resistance price levels
Overall Wall Street Rating
CC Stock IQ
Stock Insights
Strengths

Trading below its fair value
Risk Analysis

Earnings are forecast to decrease

Downgraded on weak valued
CC Latest Analysis
Following Successful Fluid Qualification Chemours & 2CRSi Join Forces to Accelerate Deployment of Two-Phase Liquid Cooling for High-Density Servers & IT Equipment. Successful qualification of Opteon™. fluid in 2CRSi server sparks broader collaboration to drive innovation in new and existing technologies across respective portfoliosWILMINGTON Del. and STRASBOURG France Feb. 24 2026 /PRNewswire/ -- The Chemours Company (NYSE:CC) a global chemistry company and 2CRSi (ISIN code: FR0013341781)
Tue Feb 24, 2026
Following Successful Fluid Qualification Chemours &. 2CRSi Join Forces to Accelerate Deployment of Two-Phase Liquid Cooling for High-Density Servers &. IT Equipment. Successful qualification of Opteon™ fluid in 2CRSi server sparks broader collaboration to drive innovation in new and existing technologies across respective portfolios WILMINGTON Del. and STRASBOURG France Feb. 24 2026 /PRNewswire/ -- The Chemours Company (NYSE: CC) a global...
Tue Feb 24, 2026
Chemours Q4 Earnings Surpass Estimates Revenues In Line. CC posts a wider y/y loss in Q4 as sales dip 2% but the bottom line beats estimates and Thermal & Specialized Solutions surges on strong refrigerant pricing.
Mon Feb 23, 2026
Chemours: No Rush To Buy The Dip Given Non-AI Pressures (Downgrade).
Mon Feb 23, 2026
Why Chemours Plunged Today. Key PointsChemours met revenue expectations but missed profit expectations in the fourth quarter.
Fri Feb 20, 2026
Chemours slides 11% on Q4 weakness in advanced performance materials.
Fri Feb 20, 2026
Chemours (CC) Beats Q4 Earnings Estimates. Chemours (CC) delivered earnings and revenue surprises of 2400.00% and 0.00% respectively for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Thu Feb 19, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.